India Approves Its First Dengue Vaccine

The government on Tuesday said Takeda Biopharmaceuticals India's dengue vaccine, QDENGA, has been granted market authorisation after a comprehensive scientific evaluation of its quality, safety and efficacy. 

This is the first dengue vaccine approved in the country for the prevention of the disease, the Health Ministry said. 

Takeda Biopharmaceuticals



India Pvt Ltd on Monday said it has received market authorisation from the drug regulator for its dengue prevention vaccine.

In a statement, the Health Ministry said the Central Drugs Standard Control Organisation (CDSCO) has granted marketing authorisation for the dengue tetravalent vaccine manufactured by Takeda GmbH, Germany and to be imported by M/s Takeda Biopharmaceuticals India Pvt. Ltd.